| ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer C Cai, H Wang, HH He, S Chen, L He, F Ma, L Mucci, Q Wang, C Fiore, ... The Journal of clinical investigation 123 (3), 1109-1122, 2013 | 194 | 2013 |
| SOX9 drives WNT pathway activation in prostate cancer F Ma, H Ye, HH He, SJ Gerrin, S Chen, BA Tanenbaum, C Cai, ... The Journal of clinical investigation 126 (5), 1745-1758, 2016 | 169 | 2016 |
| Triphalangeal thumb–polysyndactyly syndrome and syndactyly type IV are caused by genomic duplications involving the long range, limb-specific SHH enhancer M Sun, F Ma, X Zeng, Q Liu, XL Zhao, FX Wu, GP Wu, ZF Zhang, B Gu, ... Journal of medical genetics 45 (9), 589-595, 2008 | 136 | 2008 |
| Mutation analysis of five candidate genes in Chinese patients with hypospadias Y Wang, Q Li, J Xu, Q Liu, W Wang, Y Lin, F Ma, T Chen, S Li, Y Shen European Journal of Human Genetics 12 (9), 706-712, 2004 | 136 | 2004 |
| The efficacy and safety of anti-PD-1/PD-L1 antibodies for treatment of advanced or refractory cancers: a meta-analysis T Zhang, J Xie, S Arai, L Wang, X Shi, N Shi, F Ma, S Chen, L Huang, ... Oncotarget 7 (45), 73068, 2016 | 134 | 2016 |
| Androgen receptor tumor suppressor function is mediated by recruitment of retinoblastoma protein S Gao, Y Gao, HH He, D Han, W Han, A Avery, JA Macoska, X Liu, ... Cell reports 17 (4), 966-976, 2016 | 93 | 2016 |
| Copy-number mutations on chromosome 17q24. 2-q24. 3 in congenital generalized hypertrichosis terminalis with or without gingival hyperplasia M Sun, N Li, W Dong, Z Chen, Q Liu, Y Xu, G He, Y Shi, X Li, J Hao, Y Luo, ... The American Journal of Human Genetics 84 (6), 807-813, 2009 | 79 | 2009 |
| SOX9 regulates low density lipoprotein receptor-related protein 6 (LRP6) and T-cell factor 4 (TCF4) expression and Wnt/β-catenin activation in breast cancer H Wang, L He, F Ma, MM Regan, SP Balk, AL Richardson, X Yuan Journal of Biological Chemistry 288 (9), 6478-6487, 2013 | 76 | 2013 |
| Neoadjuvant-intensive androgen deprivation therapy selects for prostate tumor foci with diverse subclonal oncogenic alterations AG Sowalsky, H Ye, M Bhasin, EM Van Allen, M Loda, RT Lis, ... Cancer research 78 (16), 4716-4730, 2018 | 62 | 2018 |
| Positive feedback loop mediated by protein phosphatase 1α mobilization of P-TEFb and basal CDK1 drives androgen receptor in prostate cancer X Liu, Y Gao, HH Ye, S Gerrin, F Ma, Y Wu, T Zhang, J Russo, C Cai, ... Nucleic acids research 45 (7), 3738-3751, 2017 | 41 | 2017 |
| A ZRS duplication causes syndactyly type IV with tibial hypoplasia L Wu, D Liang, N Niikawa, F Ma, M Sun, Q Pan, Z Long, Z Zhou, ... Am J Med Genet A 149 (4), 816-818, 2009 | 36 | 2009 |
| Phosphorylation of the androgen receptor at Ser81 is co‐sustained by CDK1 and CDK9 and leads to AR‐mediated transactivation in prostate cancer XT Gao, J Liang, LY Wang, Z Zhang, P Yuan, J Wang, Y Gao, F Ma, ... Molecular Oncology 15 (7), 1901-1920, 2021 | 31 | 2021 |
| Phosphorylation of androgen receptor serine 81 is associated with its reactivation in castration-resistant prostate cancer JW Russo, X Liu, H Ye, C Calagua, S Chen, O Voznesensky, J Condulis, ... Cancer letters 438, 97-104, 2018 | 30 | 2018 |
| BMX-mediated regulation of multiple tyrosine kinases contributes to castration resistance in prostate cancer S Chen, C Cai, AG Sowalsky, H Ye, F Ma, X Yuan, NI Simon, NS Gray, ... Cancer research 78 (18), 5203-5215, 2018 | 25 | 2018 |
| Autocrine canonical Wnt signaling primes noncanonical signaling through ROR1 in metastatic castration-resistant prostate cancer F Ma, S Arai, K Wang, C Calagua, AR Yuan, L Poluben, Z Gu, JW Russo, ... Cancer research 82 (8), 1518-1533, 2022 | 21 | 2022 |
| WNT5a signaling through ROR2 activates the hippo pathway to suppress YAP1 activity and tumor growth K Wang, F Ma, S Arai, Y Wang, A Varkaris, L Poluben, O Voznesensky, ... Cancer research 83 (7), 1016-1030, 2023 | 18 | 2023 |
| Detection of chromosome aberrations in Chinese children with autism using G-banding and BAC FISH. QJ Liu, F Ma, D Li, XW Wang, WY Tian, Y Chen, JB Feng, X Lu, DQ Chen, ... Zhonghua yi xue yi Chuan xue za zhi= Zhonghua Yixue Yichuanxue Zazhi …, 2005 | 5 | 2005 |
| Abstract A024: Prostate cancer neoadjuvant intensive androgen deprivation therapy selects for tumor foci with diverse oncogenic alterations AG Sowalsky, H Ye, M Bhasin, EMV Allen, M Loda, RT Lis, L Montaser, ... Cancer Research 78 (16_Supplement), A024-A024, 2018 | | 2018 |
| Prostate cancer neoadjuvant intensive androgen deprivation therapy selects for tumor foci with diverse oncogenic alterations. AG Sowalsky, H Ye, M Bhasin, EM Van Allen, M Loda, RT Lis, L Montaser, ... CANCER RESEARCH 78 (16), 36-37, 2018 | | 2018 |
| Diversity of Resistance Mechanisms in Prostate Cancer after Neoadjuvant Intense Androgen Deprivation Therapy H Ye, AG Sowalsky, R Schaefer, X Yuan, SY Chen, SJ Gerrin, L Montaser, ... LABORATORY INVESTIGATION 96, 271A-271A, 2016 | | 2016 |
